Journals / Turkish Thoracic Journal / 2021 / Cilt: 22 - Sayı: 2

Evaluation of Patients with Fibrotic Interstitial Lung Disease: Preliminary results from the Turk-UIP Study

Pages
102–109
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presence of at least 1 of the symptoms suggestive of CTD, erythrocyte sedimentation rate (ESR), and antinuclear antibody (FANA) positivity rates were significantly higher in the non-IPF group (p<0.001, p=0.029, p=0.009, respectively).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Differential diagnosis of idiopathic pulmonary fibrosis (IPF) is important among fibrotic interstitial lung diseases (ILD).
📊
Key Findings & Data:This study aimed to evaluate the rate of IPF in patients with fibrotic ILD and to determine the clinical-laboratory features of patients with and without IPF that would provide the differential diagnosis of IPF.
💡
Conclusion & Impact:Presence of at least 1 of the symptoms suggestive of CTD, erythrocyte sedimentation rate (ESR), and antinuclear antibody (FANA) positivity rates were significantly higher in the non-IPF group (p<0.001, p=0.029, p=0.009, respectively).
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVE: Differential diagnosis of idiopathic pulmonary fibrosis (IPF) is important among fibrotic interstitial lung diseases (ILD). This study aimed to evaluate the rate of IPF in patients with fibrotic ILD and to determine the clinical-laboratory features of patients with and without IPF that would provide the differential diagnosis of IPF. MATERIAL AND METHODS: The study included the patients with the usual interstitial pneumonia (UIP) pattern or possible UIP pattern on thorax high-resolution computed tomography, and/or UIP pattern, probable UIP or possible UIP pattern at lung biopsy according to the 2011 ATS/ERS/JRS/ALAT guidelines. Demographics and clinical and radiological data of the patients were recorded. All data recorded by researchers was evaluated by radiology and the clinical decision board. RESULTS: A total of 336 patients (253 men, 83 women, age 65.8±9.0 years) were evaluated. Of the patients with sufficient data for diag nosis (n=300), the diagnosis was IPF in 121 (40.3%), unclassified idiopathic interstitial pneumonia in 50 (16.7%), combined pulmonary fibrosis and emphysema (CPFE) in 40 (13.3%), and lung involvement of connective tissue disease (CTD) in 16 (5.3%). When 29 patients with definite IPF features were added to the patients with CPFE, the total number of IPF patients reached 150 (50%). Rate of male sex (p<0.001), smoking history (p<0.001), and the presence of clubbing (p=0.001) were significantly high in patients with IPF. None of the women <50 years and none of the men <50 years of age without a smoking history were diagnosed with IPF. Presence of at least 1 of the symptoms suggestive of CTD, erythrocyte sedimentation rate (ESR), and antinuclear antibody (FANA) positivity rates were significantly higher in the non-IPF group (p<0.001, p=0.029, p=0.009, respectively).

🔖

Cite This Article

MÜSELLİM, B., MOĞULKOÇ, N., UZUN, O., TOKGÖZ, F. A., TÜRKTAŞ, H., ÖZDEMİR, Ö. K., OKUMUŞ, G., OĞUŞ, C., DİROL, H., ZAMANI, A., SEVİM, T., ANNAKKAYA, A. N., ÖZYÜREK, B. A., HANTA, İ., AYDEMİR, Y., ÇAKIR, E. E., KURT, B., TERTEMİZ, K. C., TABAK, L., YAZICI, O., Yu, Y. (2021). Evaluation of Patients with Fibrotic Interstitial Lung Disease: Preliminary results from the Turk-UIP Study. Turkish Thoracic Journal, Cilt: 22 - Sayı: 2, 102–109. https://ajindex.com/articles/418099

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Lopez-Campos JL, Rodriguez-Becerra E. The Nemours Task Group
  2. Registry of Interstitial Lung Diseases. Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study. Eur J Epidemiol 2004
  3. [CrossRef] 2. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994
  4. [CrossRef] 3. Musellim B, Okumus G, Uzaslan E, et al. Epidemiology and distribution of interstitial lung diseases in Turkey. Clin Respir J 2014
  5. [CrossRef] 4. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011
  6. [CrossRef] 5. Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis
  7. an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018
  8. e44- e68. [CrossRef] 6. Raghu G, Lynch D, Godwin JD, et al. Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial. Lancet Respir Med 2014
  9. [CrossRef] 7. Walsh SLF, Calandriello L, Sverzellati N, Wells AU, Hansell DM, UIP Observer Consort. Interobserver agreement for the ATS/ERS/ JRS/ALAT criteria for a UIP pattern on CT. Thorax 2016
  10. [CrossRef] 8. Kondoh Y, Taniguchi H, Kataoka K, et al. Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy. PLoS One 2018
  11. e0193608. [CrossRef] 9. Morell F, Villar A, Montero MÁ, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med 2013
  12. [CrossRef] 10. Singh S, Collins BF, Sharma BB, et al. Interstitial lung disease in India. Results of a prospective registry. Am J Respir Crit Care Med. 2017
  13. [CrossRef] 11. Ryerson CJ, Corte TJ, Lee JS, et al. A standardized diagnostic ontology for fibrotic interstitial lung disease: an international working group perspective. Am J Respir Crit Care Med 2017
  14. [CrossRef] 12. Culver DA, Behr J, Belperio JA, et al. Patient registries in idiopathic pulmonary fibrosis. Am J Recircuit Care Med 2019
  15. [CrossRef] 13. Behr J, Kreuter M, Hoeper MM, et al. Management of patients with idiopathic pulmonary